Mythics, LLC Appoints Sundar Padmanaban as Executive Vice President, Consulting Sales & Solution Engineering, to Drive Transformative Growth

Mythics, LLC, an award-winning Oracle solutions provider, systems integrator and consulting and managed services firm, ...
Business Insider

Orchestra BioMed™ Appoints Drug-Device Combination Expert Jagdish Parasrampuria as Vice President of Pharmaceutical Development

NEW HOPE, Pa., July 13, 2020 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic products ...
Business Insider

Orchestra BioMed™ Enhances Management Team with Appointment of Regulatory Affairs and Combination Product Expert Bob Laughner as Vice President, Regulatory Affairs

NEW HOPE, Pa., April 28, 2020 (GLOBE NEWSWIRE) -- Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing transformative therapeutic products for large ...
Targeted Oncology

Interim Efficacy Data Favor Belzutifan/Lenvatinib in Advanced RCC

At an interim analysis of the phase 3 LITESPARK-011 trial (NCT04586231), the oral combination of belzutifan (Welireg) plus ...
Morningstar

Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing

PRINCETON, N.J., Oct. 21, 2025 /PRNewswire/ -- Kenox Pharmaceuticals Inc. has announced the appointment of Dr. Julianne Berry as Vice President of R&D and Manufacturing. In her new role, Dr. Berry ...
ZAWYA

Egypt boosts electrical appliance exports to Europe and America with new agreements

Unionaire Group for Electrical Appliances participated in the Electrotech Exhibition for Electrical and Home Appliances ...
Business Wire

Exelixis Announces Encouraging Results from Phase 1b/2 STELLAR-001 Trial Evaluating Zanzalintinib Alone or in Combination with an Immune Checkpoint Inhibitor in Metastatic ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced results from an expansion cohort of the phase 1b/2 STELLAR-001 trial evaluating zanzalintinib alone or in combination ...